Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema

Clinical Ophthalmology

Volumn 7, Issue , 2013, Pages 1423-1428

  Pacella, Elena ^a   Vestri, Anna Rita ^b   Muscella, Roberto ^a   Carbotti, Maria Rosaria ^a   Castellucci, Massimo ^a   Coi, Luigi ^a   Turchetti, Paolo ^c   Pacella, Fernanda ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Diabetes; Intravitreal implant; Macular edema; Ozurdex

Indexed keywords

ANTIGLAUCOMA AGENT; BEVACIZUMAB; DEXAMETHASONE; HEMOGLOBIN A1C; PEGAPTANIB; RANIBIZUMAB; VASCULOTROPIN ANTIBODY;

ADULT; AGED; ARTICLE; CENTRAL MACULAR THICKNESS; CLINICAL ARTICLE; CONJUNCTIVAL HEMORRHAGE; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; EYE INFLAMMATION; EYE PAIN; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; KERATITIS; LASER COAGULATION; MALE; OCULOPLETHYSMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY; PERFORATING EYE INJURY; RETINA FLUORESCEIN ANGIOGRAPHY; SLIT LAMP; TREATMENT RESPONSE; VERY ELDERLY; VISUAL ACUITY; VITREOUS OPACITY; YAG LASER;

EID: 84983056928     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S48364     Document Type: Article

References (24)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998; 21: 1414–1431.
2. Richter B, Kohner E. Medical interventions for diabetic retinopathy. In: Wardnold R, Smeeth L, Henshaw K, editors. Evidence-Based Ophthalmology. London; UK: BMJ Books; 2004: 331–340.
3. Ciulla TA, Amador AG, Zinman B. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening and novel therapies. Diabetes Care. 2003; 26(9): 2653–2664.
4. Antcliff RJ, Marshall J. The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol. 1999; 14(4): 223–232.
5. Rechtman E, Harris A, Garzozi HJ, Ciulla TA. Pharmacologic therapies for diabetic retinopathy and diabetic macular edema. Clin Ophthalmol. 2007; 1: 383–391.
6. Pacella E, La Torre G, Impallara D, et al. Efficacy and safety of the intravitreal treatment of diabetic macular edema with pegaptanib: a 12-month follow-up. Clin Ter. 2013; 164(2): 1–3.
7. Nguyen QD, Shah SM, Khwaja AA, et al; READ-2 Study Group. Two-year outcomes of the Ranibizumab for Edema of the Macula in Diabetes (READ-2) study. Ophthalmology. 2010; 117: 2146–2151.
8. Katz B. A Phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology. 2005; 112(10): 1747–1757.
9. Starita C, Patel M, Katz B, Adamis A. Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (Macugen®) in diabetic retinopathy. Dev Ophthalmol. 2007; 39: 122–148.
10. Scott IU, Edwards AR, Beck RW, et al. A Phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology. 2007; 114: 1860–1867.
11. Zucchiatti I, Lattanzio R, Queques G, et al. Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. Ophthalmologica. 2012; 228: 117–122.
12. Funatsu H, Noma H, Mimura T, et al. Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology. 2009; 116: 73–79.
13. Haller JA, Dugel P, Weinberg DV, et al. Evaluation of safety and performance of an applicator for a novel intra-vitreal dexamethasone drug delivery system for the treatment of macular edema. Retina. 2009; 29: 46–51.
14. Haller JA, Kuppermann BD, Blumenkranz MS, et al. Dexamethasone DDS Phase II Study Group: randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol. 2010; 128: 289–296.
15. Rishi P, Rishi E, Kuniyal L, et al. Short-term results of intravitreal dexamethasone implant (OZURDEX®) in the treatment of recalcitrant diabetic macular edema: a case series. Oman J Ophthalmol. 2012; 5(2): 79–82.
16. Kuppermann BD, Chou C, Weinberg DV, Whitcup SM, Haller JA, Blumenkranz MS; Dexamethasone DDS Phase II Study Group. Intravitreous dexamethasone effects on different patterns of diabetic macular edema. Arch Ophthalmol. 2010; 128(5): 642–643.
17. Kuppermann BD, Blumenkranz MS, Haller JA, et al. Dexamethasone DDS Phase II Study Group: randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol. 2007; 125: 309–317.
18. Boyer DS, Faber D, Gupta S, et al; Ozurdex CHAMPLAIN Study Group. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina. 2011; 31(5): 915–923.
19. Haller JA, Bandello F, Belfort R Jr, et al. Ozurdex GENEVA Study Group: randomized, sham-controlled trial of dexa-methasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010; 117: 1134–1146.
20. Sharma A, Madhusudhan RJ, Nadahalli V, et al. Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: a case report. Indian J Ophthalmol. 2012; 60(3): 234–235.
21. Callanan DG, Gupta S, Boyer DS, et al; Ozurdex PLACID Study Group. Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. Ophthalmology. Epub May 22, 2013.
22. Bezatis A, Spital G, Höhn F, et al. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up – the SOLO study. Acta Ophthalmol. Epub May 3, 2013.
23. Schmitz K, Maier M, Clemens CR, et al. [Reliability and safety of intravitreal Ozurdex injections: the ZERO study]. Ophthalmologe. Epub April 6, 2013. German.
24. Meyer CH, Klein A, Alten F, et al. Release and velocity of micronized dexamethasone implants with an intravitreal drug delivery system: kinematic analysis with a high-speed camera. Retina. 2012; 32(10): 2133–2140.